AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Celldex Therapeutics, Inc. Director's Dealing 2017

Mar 1, 2017

31801_dirs_2017-03-01_3c74059d-b411-4281-ad7f-8b4faced9027.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2017-03-01

Reporting Person: MARINO JAMES J (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	15997	Direct